Your browser doesn't support javascript.
loading
Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs.
Camara-Wilpert, Sarah; Mayo-Muñoz, David; Russel, Jakob; Fagerlund, Robert D; Madsen, Jonas S; Fineran, Peter C; Sørensen, Søren J; Pinilla-Redondo, Rafael.
Afiliação
  • Camara-Wilpert S; Section of Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Mayo-Muñoz D; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Russel J; Genetics Otago, University of Otago, Dunedin, New Zealand.
  • Fagerlund RD; Maurice Wilkins Centre for Molecular Biodiscovery, University of Otago, Dunedin, New Zealand.
  • Madsen JS; Section of Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Fineran PC; Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Sørensen SJ; Genetics Otago, University of Otago, Dunedin, New Zealand.
  • Pinilla-Redondo R; Maurice Wilkins Centre for Molecular Biodiscovery, University of Otago, Dunedin, New Zealand.
Nature ; 623(7987): 601-607, 2023 Nov.
Article em En | MEDLINE | ID: mdl-37853129
ABSTRACT
Many bacteria use CRISPR-Cas systems to combat mobile genetic elements, such as bacteriophages and plasmids1. In turn, these invasive elements have evolved anti-CRISPR proteins to block host immunity2,3. Here we unveil a distinct type of CRISPR-Cas Inhibition strategy that is based on small non-coding RNA anti-CRISPRs (Racrs). Racrs mimic the repeats found in CRISPR arrays and are encoded in viral genomes as solitary repeat units4. We show that a prophage-encoded Racr strongly inhibits the type I-F CRISPR-Cas system by interacting specifically with Cas6f and Cas7f, resulting in the formation of an aberrant Cas subcomplex. We identified Racr candidates for almost all CRISPR-Cas types encoded by a diverse range of viruses and plasmids, often in the genetic context of other anti-CRISPR genes5. Functional testing of nine candidates spanning the two CRISPR-Cas classes confirmed their strong immune inhibitory function. Our results demonstrate that molecular mimicry of CRISPR repeats is a widespread anti-CRISPR strategy, which opens the door to potential biotechnological applications6.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bactérias / Bacteriófagos / RNA Viral / Mimetismo Molecular / Sistemas CRISPR-Cas Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bactérias / Bacteriófagos / RNA Viral / Mimetismo Molecular / Sistemas CRISPR-Cas Idioma: En Revista: Nature Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Dinamarca